NO20031876D0 - Medikamentpreparater på granulatform inneholdende forgrenede aninosyrer ogfremgangsmåter for fremstilling derav - Google Patents

Medikamentpreparater på granulatform inneholdende forgrenede aninosyrer ogfremgangsmåter for fremstilling derav

Info

Publication number
NO20031876D0
NO20031876D0 NO20031876A NO20031876A NO20031876D0 NO 20031876 D0 NO20031876 D0 NO 20031876D0 NO 20031876 A NO20031876 A NO 20031876A NO 20031876 A NO20031876 A NO 20031876A NO 20031876 D0 NO20031876 D0 NO 20031876D0
Authority
NO
Norway
Prior art keywords
processes
preparation
amino acids
chain amino
preparations containing
Prior art date
Application number
NO20031876A
Other languages
English (en)
Other versions
NO20031876L (no
Inventor
Mitsuyasu Ida
Chisato Makino
Haruo Orita
Masanao Ozaki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18803686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031876(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of NO20031876D0 publication Critical patent/NO20031876D0/no
Publication of NO20031876L publication Critical patent/NO20031876L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20031876A 2000-10-26 2003-04-25 Medikamentpreparater pa granulatform inneholdende forgrenede aninosyrer og fremgangsmate for fremstilling derav NO20031876L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000326513A JP3211824B1 (ja) 2000-10-26 2000-10-26 分岐鎖アミノ酸含有医薬用顆粒製剤とその製造方法
PCT/JP2001/009332 WO2002034255A1 (fr) 2000-10-26 2001-10-24 Preparations de medicament en granules contenant des acides amines ramifies et processus de production de ce medicament

Publications (2)

Publication Number Publication Date
NO20031876D0 true NO20031876D0 (no) 2003-04-25
NO20031876L NO20031876L (no) 2003-06-14

Family

ID=18803686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031876A NO20031876L (no) 2000-10-26 2003-04-25 Medikamentpreparater pa granulatform inneholdende forgrenede aninosyrer og fremgangsmate for fremstilling derav

Country Status (4)

Country Link
EP (1) EP1334722A4 (no)
JP (1) JP3211824B1 (no)
NO (1) NO20031876L (no)
WO (1) WO2002034255A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3368898B1 (ja) 2002-01-24 2003-01-20 味の素株式会社 分岐鎖アミノ酸含有顆粒の製造方法
JP5148801B2 (ja) * 2002-09-09 2013-02-20 エスエス製薬株式会社 催眠用固形製剤
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
DE602005019319D1 (de) 2004-11-26 2010-03-25 Ucl Business Plc Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie
MX2011010262A (es) 2009-04-03 2012-01-25 Ocera Therapeutics Inc Fenil acetato de l-ornitina y metodos para elaborar el mismo.
DK2799067T3 (da) 2009-06-08 2019-06-03 Ucl Business Plc Behandling af hjerneinflammation ved anvendelse af L-Ornithin-phenylacetat
EA028395B1 (ru) 2010-10-06 2017-11-30 Осера Терапьютикс, Инк. Способы получения фенилацетата l-орнитина
KR101458670B1 (ko) * 2012-03-30 2014-11-06 주식회사 서울제약 분지쇄아미노산을 함유하는 약제학적 조성물 및 그 제조방법
CN102908337B (zh) * 2012-10-12 2014-03-05 大连医诺生物有限公司 微囊化氨基酸组合物及其制备方法
CA2968544A1 (en) 2014-11-24 2016-06-02 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
CA2995823A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
KR101736654B1 (ko) 2016-01-20 2017-05-17 서울과학기술대학교 산학협력단 분지쇄 아미노산을 포함하는 액상 현탁조성물 및 그 제조방법
JP7052722B2 (ja) * 2016-04-19 2022-04-12 味の素株式会社 造粒物およびその製造方法
JP7080215B2 (ja) * 2017-02-21 2022-06-03 Ｅａファーマ株式会社 顆粒製剤
EP3621947A4 (en) 2017-05-11 2021-03-10 Ocera Therapeutics, Inc. L-ORNITHINE PHENYLACETATE MANUFACTURING PROCESSES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177384B (it) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione
JP2534139B2 (ja) * 1989-10-09 1996-09-11 株式会社大塚製薬工場 腎不全用経口アミノ酸製剤
WO2000018372A1 (fr) * 1998-09-30 2000-04-06 Taisho Pharmaceutical Co., Ltd. Granules pour preparations orales
EP1116485A3 (de) * 2000-01-10 2002-01-16 Gerhard Dr. Gergely Instant-Granulat und Verfahren zu seiner Herstellung
JP3228288B1 (ja) * 2000-10-26 2001-11-12 味の素株式会社 分岐鎖アミノ酸含有医薬用顆粒製剤の製造方法

Also Published As

Publication number Publication date
WO2002034255A1 (fr) 2002-05-02
EP1334722A1 (en) 2003-08-13
JP3211824B1 (ja) 2001-09-25
NO20031876L (no) 2003-06-14
EP1334722A4 (en) 2007-05-23
JP2002128667A (ja) 2002-05-09

Similar Documents

Publication Publication Date Title
HK1061841A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
NO991130D0 (no) Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav
IS6205A (is) Lyfja- og næringarsamsetningar sem innihalda nauðsynlegar fitusýrur og hómósystein-lækkandi miðla
HUP0004400A3 (en) Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
NO20031876D0 (no) Medikamentpreparater på granulatform inneholdende forgrenede aninosyrer ogfremgangsmåter for fremstilling derav
HUP0203325A3 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
IL115685A (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
EE200100716A (et) Levodopa / karbidopa / entakapooni farmatseutiline preparaat
IL113625A0 (en) Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
EE200200038A (et) Konservitud farmatseutilised preparaadid
HUP0001383A3 (en) N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
AU6038601A (en) Amino acid derivatives and their use as medicines
ID30032A (id) Formulasi farmasi
DE60040903D1 (de) Aminosäuren enthaltende albuminpräparationen
AU2571499A (en) Spray drying of pharmaceutical formulations containing amino acid-based materials
HUP0400737A3 (en) Use of l-carnitine for preparation of compositions for stabilizing the proteins
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
NO20020777L (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application